Hematologic Malignancies CME: 2021
The care of patients with hematologic malignancies is evolving rapidly. These video highlights discuss new developments in the diagnosis and treatment of hematologic malignancies presented at the 2021 Annual Meeting of the American Society of Hematology (ASH).
During this one-day virtual course, faculty shared the latest updates in lymphoma, leukemia, myeloma, and stem cell transplantation. Through case-based presentations and Q&A, users gained a deeper understanding of emerging treatments available for blood cancers and blood disorders and learned how these new therapies could be integrated into daily practice.
Advances in Allogenic Transplantation
Professor of Medicine, Harvard Medical School
Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia and the Myeloproliferative Neoplasms
Institute Physician
Professor of Medicine, Harvard Medical School
Chronic Lymphocytic Leukemia Updates
Myelodysplastic Syndromes and Acute Myeloid Leukemia
Director, Translational Research, Adult Leukemia Program
Institute Physician
Professor of Medicine, Harvard Medical School
Physician
Instructor in Medicine, Harvard Medical School
Hemostasis and Hemoglobinopathies
Assistant Director, Brigham and Women's Hospital Outpatient Infusion Center
Director, Brigham and Women's Hospital Sickle Cell Program
Instructor in Medicine, Harvard Medical School